CYTK

CYTK R&D to Revenue

461.05%Fiscal year

Period ending:

CYTK FY R&D/Revenue%
CYTK FY R&D/Revenue4910.20%-526.09%
2000-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

CYTK r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 26 observations from Dec 31, 2000 to Dec 31, 2025.

Cytokinetics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
461.0468%
1,837.2199%
4,384.1036%
254.5915%
227.0943%
173.6602%
320.5486%
282.9593%
675.4638%
56.2905%
161.9024%
94.6442%
161.3482%
471.5306%
929.55%
1,475.0873%
48.8607%
434.38%
391.9248%
1,574.1925%
455.2289%
296.7192%
321.49%
249.4208%
247.5904%
0%

Compare r&d to revenue

All CYTK financial metrics · CYTK stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.